MREO
Mereo BioPharma Group PLC ADR
NASDAQ: MREO · HEALTHCARE · BIOTECHNOLOGY
$0.27
-2.89% today
Updated 2026-04-30
Market cap
$44.72M
P/E ratio
—
P/S ratio
89.45x
EPS (TTM)
$-0.25
Dividend yield
—
52W range
$0 – $3
Volume
1.6M
Mereo BioPharma Group PLC ADR (MREO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-7,711.00%
ROE
-82.20%
ROA
-39.40%
Debt/equity
0.01x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2015 | $0.00 | $-12.19M | — | — | — |
| 2016 | $0.00 | $-28.39M | — | — | — |
| 2017 | $-3.29M | $-38.80M | 1,153.38% | 1,378.99% | 1,180.99% |
| 2018 | $0.00 | $-32.03M | — | — | — |
| 2019 | $-122000.00 | $-44.45M | 1,649.05% | 41,322.44% | 36,435.94% |
| 2020 | $393000.00 | $-209.83M | -521.75% | -12,258.72% | -53,391.63% |
| 2021 | $49.21M | $17.17M | 50.89% | -57.42% | 34.90% |
| 2022 | $1.51M | $-42.12M | 17.08% | -3,561.21% | -2,795.09% |
| 2023 | $10.00M | $-29.47M | 74.26% | -284.16% | -294.66% |
| 2024 | $0.00 | $-43.25M | — | — | — |
| 2025 | $500000.00 | $-41.88M | 73.40% | -8,100.29% | -8,375.60% |